The invention realizes that a series of sulfonamido derivatives with a conserved uronamide group at the 5' position provide superior A3 receptor affinity as well as selectivity. These new adenosine agonists are sulfonamido deritatives N-substituted with aliphatic groups (cyclic or linear) or aromatic radicals.
申请公布号
WO2005028489(A2)
申请公布日期
2005.03.31
申请号
WO2004US30514
申请日期
2004.09.17
申请人
KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.;BARALDI, PIER, GIOVANNI;MOORMAN, ALLAN, R.;BOREA, PIER, A.
发明人
BARALDI, PIER, GIOVANNI;MOORMAN, ALLAN, R.;BOREA, PIER, A.